Annual Cash & Cash Equivalents
$94.61 M
-$150.06 M-61.33%
December 31, 2022
Summary
- As of February 9, 2025, THRX annual cash & cash equivalents is $94.61 million, with the most recent change of -$150.06 million (-61.33%) on December 31, 2022.
- During the last 3 years, THRX annual cash & cash equivalents has risen by +$93.29 million (+7083.37%).
Performance
THRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$46.89 M
-$572.00 K-1.21%
September 30, 2023
Summary
- As of February 9, 2025, THRX quarterly cash and cash equivalents is $46.89 million, with the most recent change of -$572.00 thousand (-1.21%) on September 30, 2023.
- Over the past year, THRX quarterly cash and cash equivalents has dropped by -$68.67 million (-59.42%).
Performance
THRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
THRX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -61.3% | -59.4% |
| 3 y3 years | +7083.4% | - |
| 5 y5 years | +7083.4% | - |
THRX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.3% | at low | -80.8% | at low |
| 5 y | 5-year | -61.3% | -98.6% | -80.8% | -82.0% |
| alltime | all time | -61.3% | -98.6% | -80.8% | -82.0% |
Theseus Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $46.89 M(-1.2%) |
| Jun 2023 | - | $47.47 M(-56.7%) |
| Mar 2023 | - | $109.70 M(+16.0%) |
| Dec 2022 | $94.61 M | $94.61 M(-18.1%) |
| Sep 2022 | - | $115.56 M(-14.5%) |
| Jun 2022 | - | $135.09 M(-7.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $146.28 M(-40.2%) |
| Dec 2021 | $244.66 M(+2793.0%) | $244.66 M(+170.6%) |
| Sep 2021 | - | $90.40 M(-7.4%) |
| Jun 2021 | - | $97.59 M(+1053.9%) |
| Dec 2020 | $8.46 M(+542.1%) | $8.46 M |
| Dec 2019 | $1.32 M | - |
FAQ
- What is Theseus Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Theseus Pharmaceuticals?
- What is Theseus Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Theseus Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Theseus Pharmaceuticals?
- What is Theseus Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Theseus Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of THRX is $94.61 M
What is the all time high annual cash & cash equivalents for Theseus Pharmaceuticals?
Theseus Pharmaceuticals all-time high annual cash & cash equivalents is $244.66 M
What is Theseus Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, THRX annual cash & cash equivalents has changed by -$150.06 M (-61.33%)
What is Theseus Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of THRX is $46.89 M
What is the all time high quarterly cash and cash equivalents for Theseus Pharmaceuticals?
Theseus Pharmaceuticals all-time high quarterly cash and cash equivalents is $244.66 M
What is Theseus Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, THRX quarterly cash and cash equivalents has changed by -$68.67 M (-59.42%)